Integrated Wealth Concepts LLC Grows Position in Chemed Corporation $CHE

Integrated Wealth Concepts LLC raised its stake in shares of Chemed Corporation (NYSE:CHE) by 9.7% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 27,774 shares of the company’s stock after purchasing an additional 2,461 shares during the period. Integrated Wealth Concepts LLC’s holdings in Chemed were worth $12,936,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of CHE. Geneos Wealth Management Inc. increased its holdings in shares of Chemed by 330.4% during the 1st quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock worth $61,000 after buying an additional 76 shares during the last quarter. Arrowstreet Capital Limited Partnership raised its position in shares of Chemed by 67.0% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 11,365 shares of the company’s stock worth $5,534,000 after buying an additional 4,560 shares during the period. Marshall Wace LLP acquired a new position in Chemed in the second quarter valued at $579,000. Brown Advisory Inc. boosted its holdings in Chemed by 36.9% in the second quarter. Brown Advisory Inc. now owns 549 shares of the company’s stock valued at $267,000 after acquiring an additional 148 shares during the last quarter. Finally, Cerity Partners LLC boosted its holdings in Chemed by 237.7% in the second quarter. Cerity Partners LLC now owns 4,451 shares of the company’s stock valued at $2,165,000 after acquiring an additional 3,133 shares during the last quarter. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Chemed Price Performance

Shares of CHE stock opened at $518.12 on Thursday. The company has a market capitalization of $6.77 billion, a PE ratio of 26.02, a price-to-earnings-growth ratio of 1.97 and a beta of 0.51. The firm has a fifty day simple moving average of $519.73 and a 200-day simple moving average of $452.69. The company has a current ratio of 0.91, a quick ratio of 0.89 and a debt-to-equity ratio of 0.17. Chemed Corporation has a twelve month low of $365.20 and a twelve month high of $557.00.

Chemed (NYSE:CHE) last released its quarterly earnings results on Tuesday, July 28th. The company reported $6.06 earnings per share for the quarter, beating analysts’ consensus estimates of $5.60 by $0.46. Chemed had a net margin of 10.60% and a return on equity of 31.77%. The business had revenue of $673.25 million during the quarter, compared to analyst estimates of $665.04 million. During the same period last year, the business earned $4.27 EPS. The business’s revenue was up 8.8% on a year-over-year basis. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. Equities research analysts anticipate that Chemed Corporation will post 23.18 earnings per share for the current fiscal year.

Chemed Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, September 3rd. Stockholders of record on Monday, August 17th were paid a dividend of $0.70 per share. This is a boost from Chemed’s previous quarterly dividend of $0.60. This represents a $2.80 annualized dividend and a dividend yield of 0.5%. The ex-dividend date was Monday, August 17th. Chemed’s payout ratio is 14.06%.

Insider Activity

In related news, EVP Spencer S. Lee sold 1,000 shares of the business’s stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $541.04, for a total value of $541,040.00. Following the transaction, the executive vice president owned 13,912 shares in the company, valued at approximately $7,526,948.48. The trade was a 6.71% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Patrick P. Grace sold 190 shares of the stock in a transaction dated Friday, July 31st. The shares were sold at an average price of $532.00, for a total value of $101,080.00. Following the completion of the transaction, the director directly owned 3,533 shares of the company’s stock, valued at $1,879,556. This represents a 5.10% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 5,190 shares of company stock worth $2,803,460 over the last ninety days. Corporate insiders own 3.33% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have commented on CHE shares. Wall Street Zen upgraded Chemed from a “hold” rating to a “strong-buy” rating in a report on Saturday, August 1st. Weiss Ratings upgraded Chemed from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, July 17th. Royal Bank Of Canada increased their target price on shares of Chemed from $436.00 to $548.00 and gave the stock a “sector perform” rating in a research report on Thursday, July 30th. Oppenheimer raised their price target on shares of Chemed from $500.00 to $590.00 and gave the company an “outperform” rating in a report on Friday, July 31st. Finally, Bank of America restated a “neutral” rating on shares of Chemed in a report on Wednesday, July 29th. One investment analyst has rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $530.75.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.